Mansol, Kahalan W.
HRN: 27-30-75 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/14/2025
CLINDAMYCIN 150MG/ML, 4ML (AMP)
06/14/2025
06/21/2025
IV
300MG
Q8
BACTEREMIA: STAPH HOMINIS
Waiting Final Action
Indication: Culture-directed Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes